Y Intercept Hong Kong Ltd Sells 206,062 Shares of Sotera Health Company $SHC

Y Intercept Hong Kong Ltd lowered its stake in Sotera Health Company (NASDAQ:SHC) by 94.3% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 12,393 shares of the company’s stock after selling 206,062 shares during the period. Y Intercept Hong Kong Ltd’s holdings in Sotera Health were worth $178,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of the stock. IFP Advisors Inc increased its stake in shares of Sotera Health by 1,105.6% during the fourth quarter. IFP Advisors Inc now owns 1,495 shares of the company’s stock worth $26,000 after purchasing an additional 1,371 shares during the period. Rothschild Investment LLC acquired a new position in Sotera Health in the 4th quarter valued at $27,000. Root Financial Partners LLC increased its position in Sotera Health by 217.5% during the 1st quarter. Root Financial Partners LLC now owns 2,124 shares of the company’s stock worth $30,000 after buying an additional 1,455 shares during the period. True Wealth Design LLC lifted its holdings in shares of Sotera Health by 389.3% during the fourth quarter. True Wealth Design LLC now owns 1,830 shares of the company’s stock worth $32,000 after buying an additional 1,456 shares in the last quarter. Finally, EverSource Wealth Advisors LLC lifted its holdings in shares of Sotera Health by 831.4% during the second quarter. EverSource Wealth Advisors LLC now owns 3,288 shares of the company’s stock worth $37,000 after buying an additional 2,935 shares in the last quarter. 91.03% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on the stock. Weiss Ratings raised shares of Sotera Health from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, July 9th. The Goldman Sachs Group initiated coverage on shares of Sotera Health in a research note on Friday, June 5th. They issued a “buy” rating and a $20.00 price objective for the company. Piper Sandler reissued an “overweight” rating and issued a $22.00 price objective (down from $24.00) on shares of Sotera Health in a report on Wednesday, May 6th. Barclays increased their target price on shares of Sotera Health from $18.00 to $19.00 and gave the stock an “overweight” rating in a research report on Wednesday, June 24th. Finally, Wall Street Zen cut shares of Sotera Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, April 11th. Eight investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $20.25.

Insider Transactions at Sotera Health

In related news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of Sotera Health stock in a transaction that occurred on Wednesday, May 13th. The shares were sold at an average price of $15.17, for a total value of $193,194,516.17. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. 15.36% of the stock is owned by company insiders.

Sotera Health Trading Up 2.1%

SHC opened at $18.15 on Thursday. The stock has a market capitalization of $5.18 billion, a price-to-earnings ratio of 44.27 and a beta of 1.76. The company has a quick ratio of 2.54, a current ratio of 2.82 and a debt-to-equity ratio of 3.56. Sotera Health Company has a twelve month low of $10.94 and a twelve month high of $19.85. The company has a 50-day simple moving average of $16.37 and a 200 day simple moving average of $16.39.

Sotera Health (NASDAQ:SHC) last released its earnings results on Tuesday, May 5th. The company reported $0.18 EPS for the quarter, beating the consensus estimate of $0.17 by $0.01. The firm had revenue of $280.05 million for the quarter, compared to analyst estimates of $270.78 million. Sotera Health had a net margin of 9.91% and a return on equity of 39.73%. The business’s quarterly revenue was up 10.0% compared to the same quarter last year. During the same period last year, the firm earned $0.14 EPS. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. Analysts predict that Sotera Health Company will post 0.87 EPS for the current fiscal year.

Sotera Health Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.